HLA‐A,B,C and DR antigens, GLO I and Bf marker profiles in 75 Cape Coloured patients with systemic lupus erythematosus (SLE)

Abstract
HLA-A,B,C and DR antigens were tested in 75 Cape Coloured systemic lupus erythematous (SLE) patients, and the GLO I and Bf markes in 51. The patients with HLA-DR2 had a relative risk significantly greater than one (p = 0.0005). Twenty-two (29%) patients had only one detectable DR antigen. Of these, 11 (50%) were found to have DR2 only. The HLA-DR7 antigen was associated with severe disease (p < 0.02). Bf and GLO I markers were not associated with SLE.